NEWS RELEASE |
3Q18 3 months ended 12/31/17 | 2Q18 3 months ended 9/30/17 | + favorable / - unfavorable | |
Revenue | $13.7M | $17.2M | -$3.5M |
Gross Margin | 44.4% | 42.2% | +2.2% |
Operating Expenses | $6.0M | $7.2M | +$1.2M |
Operating Margin | 0.3% | 0.3% | —% |
Net Income | $0.8M | $0.7M | +$0.1M |
Earnings Per Share | $0.05 | $0.05 | $— |
Non-GAAP Operating Expenses (1) | $4.7M | $5.7M | +$1.0M |
Non-GAAP Operating Margin (1) | 10.2% | 9.3% | +0.9% |
Non-GAAP Net Income (1) | $1.5M | $1.7M | -$0.2M |
Non-GAAP Earnings Per Share (1) | $0.09 | $0.11 | -$0.02 |
Non-GAAP Adjusted EBITDA (1) | $1.6M | $1.8M | -$0.2M |
(1) Please refer to the schedule at the end of this press release for a complete GAAP to non-GAAP reconciliation and other information related to non-GAAP financial measures. |
3Q18 3 months ended 12/31/17 | 2Q18 3 months ended 9/30/17 | + favorable / - unfavorable | |
IBW Segment Revenue | $5.2M | $7.9M | -$2.7M |
IBW Segment Gross Margin | 47.3% | 46.1% | +1.2% |
IBW Segment R&D Expense | $0.8M | $1.4M | +$0.6M |
IBW Segment Profit | $1.7M | $2.2M | -$0.5M |
3Q18 3 months ended 12/31/17 | 2Q18 3 months ended 9/30/17 | + favorable / - unfavorable | |
ISMS Segment Revenue | $5.8M | $4.7M | +$1.1M |
ISMS Segment Gross Margin | 54.5% | 46.9% | +7.6% |
ISMS Segment R&D Expense | $0.5M | $0.5M | $— |
ISMS Segment Profit | $2.6M | $1.7M | +$0.9M |
3Q18 3 months ended 12/31/17 | 2Q18 3 months ended 9/30/17 | + favorable / - unfavorable | |
CNS Segment Revenue | $2.7M | $4.6M | -$1.9M |
CNS Segment Gross Margin | 16.9% | 30.7% | -13.8% |
CNS Segment R&D Expense | $0.2M | $0.2M | $— |
CNS Segment Profit | $0.2M | $1.2M | -$1.0M |
Three months ended | Nine months ended | ||||||||||||||||||||
December 31, | September 30, | December 31, | December 31, | December 31, | |||||||||||||||||
2017 | 2017 | 2016 | 2017 | 2016 | |||||||||||||||||
Revenue: | |||||||||||||||||||||
Products | $ | 11,754 | $ | 16,097 | $ | 12,746 | $ | 43,396 | $ | 42,240 | |||||||||||
Services | 1,921 | 1,135 | 2,237 | 4,085 | 5,339 | ||||||||||||||||
Total revenue | 13,675 | 17,232 | 14,983 | 47,481 | 47,579 | ||||||||||||||||
Cost of revenue: | |||||||||||||||||||||
Products | 7,114 | 9,522 | 7,807 | 26,060 | 27,788 | ||||||||||||||||
Services | 485 | 435 | 1,122 | 1,303 | 2,805 | ||||||||||||||||
Total cost of revenue | 7,599 | 9,957 | 8,929 | 27,363 | 30,593 | ||||||||||||||||
Gross profit | 6,076 | 7,275 | 6,054 | 20,118 | 16,986 | ||||||||||||||||
Gross margin | 44.4 | % | 42.2 | % | 40.4 | % | 42.4 | % | 35.7 | % | |||||||||||
Operating expenses: | |||||||||||||||||||||
R&D | 1,542 | 2,205 | 2,414 | 6,023 | 10,018 | ||||||||||||||||
Sales and marketing | 1,950 | 1,992 | 1,943 | 6,278 | 8,220 | ||||||||||||||||
General and administrative | 1,502 | 1,809 | 1,777 | 5,022 | 6,340 | ||||||||||||||||
Intangible amortization | 1,047 | 1,048 | 1,212 | 3,142 | 3,613 | ||||||||||||||||
Restructuring | — | 165 | (1) | 490 | (2) | 165 | (1) | 3,055 | (2) | ||||||||||||
Long-lived assets impairment | — | — | — | — | 1,181 | (3) | |||||||||||||||
Total operating expenses | 6,041 | 7,219 | 7,836 | 20,630 | 32,427 | ||||||||||||||||
Operating profit (loss) | 35 | 56 | (1,782 | ) | (512 | ) | (15,441 | ) | |||||||||||||
Other income, net | 79 | 677 | (4) | (15 | ) | 799 | (4) | 76 | |||||||||||||
Income (loss) before income taxes | 114 | 733 | (1,797 | ) | 287 | (15,365 | ) | ||||||||||||||
Income tax benefit (expense) | 685 | (5) | (13 | ) | (10 | ) | 660 | (5) | (20 | ) | |||||||||||
Net income (loss) | $ | 799 | $ | 720 | $ | (1,807 | ) | $ | 947 | $ | (15,385 | ) | |||||||||
Net income (loss) per share: | |||||||||||||||||||||
Basic net income (loss) | $ | 0.05 | $ | 0.05 | $ | (0.12 | ) | (6) | $ | 0.06 | $ | (1.00 | ) | (6) | |||||||
Diluted net income (loss) | $ | 0.05 | $ | 0.05 | $ | (0.12 | ) | (6) | $ | 0.06 | $ | (1.00 | ) | (6) | |||||||
Weighted-average number of common shares outstanding: | |||||||||||||||||||||
Basic | 15,504 | 15,461 | 15,391 | (6) | 15,482 | 15,315 | (6) | ||||||||||||||
Diluted | 15,755 | 15,672 | 15,391 | (6) | 15,679 | 15,315 | (6) |
(1) | 2Q18 restructuring expense related to severance costs for terminated employees. |
(2) | The Company recorded restructuring expense primarily relating to abandonment of excess office space at its headquarters and in New Hampshire, and severance costs for terminated employees. |
(3) | 1Q17 non-cash impairment related to long-lived assets associated with the discontinuation of ClearLink DAS. |
(4) | During the quarter ended September 30, 2017, the Company dissolved the NoranTel legal entity which triggered a one-time $0.6 million foreign currency gain with the reversal of a cumulative translation adjustment. |
(5) | During the quarter ended December 31, 2017, the Company had an income tax benefit of $697K from the release of the tax valuation allowance associated with previously generated alternative minimum tax (AMT) credits due to the enactment of the Tax Cuts and Jobs Act of 2017. |
(6) | All common stock, equity, share and per share amounts have been retroactively adjusted to reflect a one-for-four reverse stock split which was effective June 7, 2017. |
December 31, 2017 (Unaudited) | March 31, 2017 | |||||||
Assets | ||||||||
Cash and cash equivalents | $ | 21,492 | $ | 21,778 | ||||
Short-term investments | 4,537 | — | ||||||
Accounts receivable, net | 11,070 | 12,075 | ||||||
Inventories | 9,464 | 12,511 | ||||||
Prepaid expenses and other current assets | 864 | 1,409 | ||||||
Total current assets | 47,427 | 47,773 | ||||||
Land, property and equipment, net | 1,630 | 1,984 | ||||||
Intangible assets, net | 12,482 | 15,624 | ||||||
Tax receivable, non-current | 697 | — | ||||||
Other non-current assets | 80 | 160 | ||||||
Total assets | $ | 62,316 | $ | 65,541 | ||||
Liabilities and Stockholders’ Equity | ||||||||
Accounts payable | $ | 2,494 | $ | 4,163 | ||||
Accrued expenses | 3,528 | 4,273 | ||||||
Accrued restructuring | 166 | 1,171 | ||||||
Deferred revenue | 1,931 | 2,359 | ||||||
Total current liabilities | 8,119 | 11,966 | ||||||
Deferred revenue non-current | 912 | 1,102 | ||||||
Accrued restructuring non-current | — | 63 | ||||||
Other non-current liabilities | 341 | 236 | ||||||
Total liabilities | 9,372 | 13,367 | ||||||
Total stockholders’ equity | 52,944 | 52,174 | ||||||
Total liabilities and stockholders’ equity | $ | 62,316 | $ | 65,541 |
Three months ended December 31, | Nine months ended December 31, | ||||||||||||
2017 | 2017 | 2016 | |||||||||||
Cash flows from operating activities: | |||||||||||||
Net income (loss) | $ | 799 | $ | 947 | $ | (15,385 | ) | ||||||
Reconciliation of net income (loss) to net cash used in operating activities: | |||||||||||||
Depreciation and amortization | 1,221 | 3,747 | 4,714 | ||||||||||
Long-lived assets impairment | — | — | 1,181 | (1) | |||||||||
Stock-based compensation | 316 | 988 | 1,346 | ||||||||||
Loss on sale of fixed assets | 2 | 10 | 11 | ||||||||||
Restructuring | — | 165 | 3,055 | ||||||||||
Deferred taxes | (697 | ) | (697 | ) | 20 | ||||||||
Gain on disposal of foreign operations | — | (608 | ) | (2) | — | ||||||||
Exchange rate loss (gain) | (14 | ) | (20 | ) | 44 | ||||||||
Changes in assets and liabilities: | |||||||||||||
Accounts receivable | — | 1,025 | 5,098 | ||||||||||
Inventory | 519 | 3,047 | 509 | ||||||||||
Accounts payable and accrued expenses | (1,236 | ) | (3,542 | ) | (6,802 | ) | |||||||
Deferred revenue | 859 | (618 | ) | 686 | |||||||||
Prepaid expenses and other current assets | 170 | 545 | 494 | ||||||||||
Other assets | 7 | 80 | (7 | ) | |||||||||
Net cash provided by (used in) operating activities | 1,946 | 5,069 | (5,036 | ) | |||||||||
Cash flows from investing activities: | |||||||||||||
Net maturity (purchase) of short-term investments | 474 | (4,537 | ) | 10,555 | |||||||||
Purchases of property and equipment, net | (7 | ) | (261 | ) | (527 | ) | |||||||
Net cash provided by (used in) investing activities | 467 | (4,798 | ) | 10,028 | |||||||||
Cash flows from financing activities: | |||||||||||||
Purchase of treasury stock | (102 | ) | (558 | ) | (146 | ) | |||||||
Payment of contingent consideration | — | — | (175 | ) | |||||||||
Net cash provided by (used in) financing activities | (102 | ) | (558 | ) | (321 | ) | |||||||
Gain (loss) of exchange rate changes on cash | (19 | ) | 1 | 2 | |||||||||
Net increase (decrease) in cash and cash equivalents | 2,292 | (286 | ) | 4,673 | |||||||||
Cash and cash equivalents, beginning of period | 19,200 | 21,778 | 19,169 | ||||||||||
Cash and cash equivalents, end of period | $ | 21,492 | (3) | $ | 21,492 | (3) | $ | 23,842 |
Three months ended December 31, 2017 | Three months ended September 30, 2017 | |||||||||||||||||||||||||||||||
IBW | ISMS | CNS | Total | IBW | ISMS | CNS | Total | |||||||||||||||||||||||||
Total revenue | $ | 5,223 | $ | 5,802 | $ | 2,650 | $ | 13,675 | $ | 7,919 | $ | 4,730 | $ | 4,583 | $ | 17,232 | ||||||||||||||||
Gross profit | 2,469 | 3,160 | 447 | 6,076 | 3,650 | 2,219 | 1,406 | 7,275 | ||||||||||||||||||||||||
Gross margin | 47.3 | % | 54.5 | % | 16.9 | % | 44.4 | % | 46.1 | % | 46.9 | % | 30.7 | % | 42.2 | % | ||||||||||||||||
R&D expenses | 750 | 547 | 245 | 1,542 | 1,443 | 523 | 239 | 2,205 | ||||||||||||||||||||||||
Segment profit | $ | 1,719 | $ | 2,613 | $ | 202 | $ | 4,534 | $ | 2,207 | $ | 1,696 | $ | 1,167 | $ | 5,070 |
Three months ended December 31, 2017 | Three months ended December 31, 2016 | |||||||||||||||||||||||||||||||
IBW | ISMS | CNS | Total | IBW | ISMS | CNS | Total | |||||||||||||||||||||||||
Total revenue | $ | 5,223 | $ | 5,802 | $ | 2,650 | $ | 13,675 | $ | 6,224 | $ | 5,525 | $ | 3,234 | $ | 14,983 | ||||||||||||||||
Gross profit | 2,469 | 3,160 | 447 | 6,076 | 2,511 | 2,795 | 748 | 6,054 | ||||||||||||||||||||||||
Gross margin (1) | 47.3 | % | 54.5 | % | 16.9 | % | 44.4 | % | 40.3 | % | 50.6 | % | 23.1 | % | 40.4 | % | ||||||||||||||||
R&D expenses | 750 | 547 | 245 | 1,542 | 1,307 | 805 | 302 | 2,414 | ||||||||||||||||||||||||
Segment profit | $ | 1,719 | $ | 2,613 | $ | 202 | $ | 4,534 | $ | 1,204 | $ | 1,990 | $ | 446 | $ | 3,640 |
Three months ended December 31, 2017 | Three months ended September 30, 2017 | Three months ended December 31, 2016 | |||||||||||||||||||||||||||||||
Revenue | Gross Profit | Gross Margin | Revenue | Gross Profit | Gross Margin | Revenue | Gross Profit | Gross Margin | |||||||||||||||||||||||||
GAAP - IBW segment | $ | 5,223 | $ | 2,469 | 47.3 | % | $ | 7,919 | $ | 3,650 | 46.1 | % | $ | 6,224 | $ | 2,511 | 40.3 | % | |||||||||||||||
Stock-based compensation (1) | — | 2 | — | (2 | ) | — | 2 | ||||||||||||||||||||||||||
Non-GAAP - IBW segment | $ | 5,223 | $ | 2,471 | 47.3 | % | $ | 7,919 | $ | 3,648 | 46.1 | % | $ | 6,224 | $ | 2,513 | 40.4 | % | |||||||||||||||
(1) Stock-based compensation is a non-cash expense incurred in accordance with share-based compensation accounting standards. |
Nine months ended December 31, 2017 | Nine months ended December 31, 2016 | |||||||||||||||||||||
Revenue | Gross Profit | Gross Margin | Revenue | Gross Profit | Gross Margin | |||||||||||||||||
GAAP - IBW segment | $ | 20,098 | $ | 9,133 | 45.4 | % | $ | 18,989 | $ | 5,738 | 30.2 | % | ||||||||||
ClearLink DAS E&O (1) | — | — | — | 1,581 | ||||||||||||||||||
Stock-based compensation (2) | — | 8 | — | 7 | ||||||||||||||||||
Non-GAAP - IBW segment | $ | 20,098 | $ | 9,141 | 45.5 | % | $ | 18,989 | $ | 7,326 | 38.6 | % | ||||||||||
(1) Excess and Obsolete inventory charges on ClearLink DAS inventory and firm purchase commitments. | ||||||||||||||||||||||
(2) Stock-based compensation is a non-cash expense incurred in accordance with share-based compensation accounting standards. |
Three months ended December 31, 2017 | Three months ended September 30, 2017 | Three months ended December 31, 2016 | |||||||||||||||||||||||||||||||
Revenue | Gross Profit | Gross Margin | Revenue | Gross Profit | Gross Margin | Revenue | Gross Profit | Gross Margin | |||||||||||||||||||||||||
GAAP - Consolidated | $ | 13,675 | $ | 6,076 | 44.4 | % | $ | 17,232 | $ | 7,275 | 42.2 | % | $ | 14,983 | $ | 6,054 | 40.4 | % | |||||||||||||||
Deferred revenue adjustment (1) | — | — | — | — | 64 | 64 | |||||||||||||||||||||||||||
Stock-based compensation (2) | — | 11 | — | (3 | ) | — | 10 | ||||||||||||||||||||||||||
Non-GAAP - Consolidated | $ | 13,675 | $ | 6,087 | 44.5 | % | $ | 17,232 | $ | 7,272 | 42.2 | % | $ | 15,047 | $ | 6,128 | 40.7 | % |
Three months ended | Nine months ended | |||||||||||||||||||
December 31, | September 30, | December 31, | December 31, | December 31, | ||||||||||||||||
2017 | 2017 | 2016 | 2017 | 2016 | ||||||||||||||||
GAAP consolidated operating expenses | $ | 6,041 | $ | 7,219 | $ | 7,836 | $ | 20,630 | $ | 32,427 | ||||||||||
Adjustments: | ||||||||||||||||||||
Stock-based compensation (2) | (305 | ) | (345 | ) | (243 | ) | (955 | ) | (1,322 | ) | ||||||||||
Long-lived asset impairment (3) | — | — | — | — | (1,181 | ) | ||||||||||||||
Amortization of intangibles (4) | (1,047 | ) | (1,048 | ) | (1,212 | ) | (3,142 | ) | (3,613 | ) | ||||||||||
Restructuring, separation, and transition (5) | — | (165 | ) | (490 | ) | (165 | ) | (3,055 | ) | |||||||||||
Total adjustments | (1,352 | ) | (1,558 | ) | (1,945 | ) | (4,262 | ) | (9,171 | ) | ||||||||||
Non-GAAP consolidated operating expenses | $ | 4,689 | $ | 5,661 | $ | 5,891 | $ | 16,368 | $ | 23,256 |
Three months ended | Nine months ended | |||||||||||||||||||
December 31, | September 30, | December 31, | December 31, | December 31, | ||||||||||||||||
2017 | 2017 | 2016 | 2017 | 2016 | ||||||||||||||||
GAAP consolidated net income (loss) | $ | 799 | $ | 720 | $ | (1,807 | ) | $ | 947 | $ | (15,385 | ) | ||||||||
Less: | ||||||||||||||||||||
Income tax benefit (expense) | 685 | (13 | ) | (10 | ) | 660 | (20 | ) | ||||||||||||
Other income, net | 79 | 677 | (15 | ) | 799 | 76 | ||||||||||||||
GAAP consolidated operating profit (loss) | $ | 35 | $ | 56 | $ | (1,782 | ) | $ | (512 | ) | $ | (15,441 | ) | |||||||
Adjustments: | ||||||||||||||||||||
Deferred revenue adjustment (1) | — | — | 64 | — | 190 | |||||||||||||||
ClearLink DAS E&O (6) | — | — | — | — | 1,581 | |||||||||||||||
Stock-based compensation (2) | 316 | 342 | 253 | 988 | 1,346 | |||||||||||||||
Long-lived asset impairment (3) | — | — | — | — | 1,181 | |||||||||||||||
Amortization of intangibles (4) | 1,047 | 1,048 | 1,212 | 3,142 | 3,613 | |||||||||||||||
Restructuring, separation, and transition (5) | — | 165 | 490 | 165 | 3,055 | |||||||||||||||
Total adjustments | 1,363 | 1,555 | 2,019 | 4,295 | 10,966 | |||||||||||||||
Non-GAAP consolidated operating profit (loss) | $ | 1,398 | $ | 1,611 | $ | 237 | $ | 3,783 | $ | (4,475 | ) | |||||||||
Depreciation | 174 | 201 | 272 | 605 | 1,101 | |||||||||||||||
Non-GAAP consolidated Adjusted EBITDA (7) | $ | 1,572 | $ | 1,812 | $ | 509 | $ | 4,388 | $ | (3,374 | ) |
Three months ended | Nine months ended | |||||||||||||||||||
December 31, | September 30, | December 31, | December 31, | December 31, | ||||||||||||||||
2017 | 2017 | 2016 | 2017 | 2016 | ||||||||||||||||
GAAP consolidated net income (loss) | $ | 799 | $ | 720 | $ | (1,807 | ) | $ | 947 | $ | (15,385 | ) | ||||||||
Adjustments: | ||||||||||||||||||||
Deferred revenue adjustment (1) | — | — | 64 | — | 190 | |||||||||||||||
ClearLink DAS E&O (6) | — | — | — | — | 1,581 | |||||||||||||||
Stock-based compensation (2) | 316 | 342 | 253 | 988 | 1,346 | |||||||||||||||
Long-lived asset impairment (3) | — | — | — | — | 1,181 | |||||||||||||||
Amortization of intangibles (4) | 1,047 | 1,048 | 1,212 | 3,142 | 3,613 | |||||||||||||||
Restructuring, separation, and transition (5) | — | 165 | 490 | 165 | 3,055 | |||||||||||||||
Foreign currency translation adjustment (8) | — | (608 | ) | — | (608 | ) | — | |||||||||||||
Income taxes (9) | (697 | ) | — | — | (697 | ) | — | |||||||||||||
Total adjustments | 666 | 947 | 2,019 | 2,990 | 10,966 | |||||||||||||||
Non-GAAP consolidated net income (loss) | $ | 1,465 | $ | 1,667 | $ | 212 | $ | 3,937 | $ | (4,419 | ) | |||||||||
GAAP consolidated net income (loss) per common share: | ||||||||||||||||||||
Diluted | $ | 0.05 | $ | 0.05 | $ | (0.12 | ) | $ | 0.06 | $ | (1.00 | ) | ||||||||
Non-GAAP consolidated net income (loss) per common share: | ||||||||||||||||||||
Diluted | $ | 0.09 | $ | 0.11 | $ | 0.01 | $ | 0.25 | $ | (0.29 | ) | |||||||||
Average number of common shares outstanding: | ||||||||||||||||||||
Diluted | 15,755 | 15,672 | 15,425 | 15,679 | 15,315 |
Tom Minichiello Chief Financial Officer Westell Technologies, Inc. +1 (630) 375 4740 tminichiello@westell.com |